United States · FDA National Drug Code directory
TEMODAR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0085-1381_40ceddc0-83a2-4b3b-8953-fd0078a41133
- Product NDC
- 0085-1381
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Temozolomide
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20090227
- Source listing expiry
- 20271231
Source-listed ingredients
- TEMOZOLOMIDE — 2.5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (0085-1381-01) / 40 mL in 1 VIAL, SINGLE-USE · 0085-1381-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →